Wei Lin, Chief Medical Officer of Revolution Medicines ($RVMD), made two open market sales of company shares over the past year, totaling $185,532. His most recent sale occurred on September 16, 2025. These sales rank 8,571st among 11,678 insiders in our database, where the average is $8.6 million across about six transactions per insider. Wei Lin reported no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 17, 2026 | Revolution Medicines, Inc. | $RVMD | Wei Lin | Chief Medical Officer | S | Common Stock | 2073 | $99.48 | 101,366.0000 | 193,319,805 | 2.00% | 0.00% |
| March 1, 2026 | Revolution Medicines, Inc. | $RVMD | Wei Lin | Chief Medical Officer | A | Stock Option (Right to Buy) | 34000 | $0.00 | 34,000.0000 | 193,319,805 | 9999.99% | 0.02% |
| March 1, 2026 | Revolution Medicines, Inc. | $RVMD | Wei Lin | Chief Medical Officer | A | Common Stock | 15100 | $0.00 | 103,439.0000 | 193,319,805 | 17.09% | 0.01% |
| Sept. 16, 2025 | Revolution Medicines, Inc. | $RVMD | Wei Lin | Chief Medical Officer | S | Common Stock | 2160 | $45.82 | 88,339.0000 | 185,913,326 | 2.39% | 0.00% |
| June 16, 2025 | Revolution Medicines, Inc. | $RVMD | Wei Lin | Chief Medical Officer | S | Common Stock | 2173 | $39.83 | 90,499.0000 | 185,913,326 | 2.34% | 0.00% |
| March 1, 2025 | Revolution Medicines, Inc. | $RVMD | Wei Lin | Chief Medical Officer | A | Stock Option (Right to Buy) | 72800 | $0.00 | 72,800.0000 | 185,913,326 | 9999.99% | 0.04% |
| March 1, 2025 | Revolution Medicines, Inc. | $RVMD | Wei Lin | Chief Medical Officer | A | Common Stock | 20800 | $0.00 | 91,651.0000 | 185,913,326 | 18.50% | 0.01% |
| June 17, 2024 | Revolution Medicines, Inc. | $RVMD | Wei Lin | Chief Medical Officer | S | Common Stock | 5589 | $37.39 | 70,851.0000 | 0 | 7.31% | 0.00% |
| Feb. 1, 2023 | Erasca, Inc. | $ERAS | Wei Lin | Chief Medical Officer | J | Common Stock | 2 | $3.89 | 315,812.0000 | 0 | 0.00% | 0.00% |
| Feb. 1, 2023 | Erasca, Inc. | $ERAS | Wei Lin | Chief Medical Officer | J | Common Stock | 1748 | $4.10 | 315,812.0000 | 0 | 0.56% | 0.00% |
| Feb. 1, 2023 | Erasca, Inc. | $ERAS | Wei Lin | Chief Medical Officer | A | Stock Option (right to buy) | 560000 | $0.00 | 560,000.0000 | 0 | 9999.99% | 0.00% |